abstract |
The present invention comprises administering a pharmaceutically acceptable salt of 5α-pregnan-3β-ol-20-one 3-sulfate ester to a mammal in need of progesterone therapy in an effective amount of progesterone, Provided are methods of providing hormonal therapy to a subject. |